Corteva, Inc. (NYSE:CTVA) Shares Sold by Capital International Ltd. CA

Capital International Ltd. CA reduced its stake in Corteva, Inc. (NYSE:CTVA) by 59.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 59,935 shares of the company’s stock after selling 86,651 shares during the period. Capital International Ltd. CA’s holdings in Corteva were worth $2,872,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. CVA Family Office LLC acquired a new position in Corteva in the fourth quarter valued at approximately $25,000. BKM Wealth Management LLC bought a new stake in shares of Corteva during the fourth quarter valued at approximately $27,000. Naples Money Management LLC bought a new stake in shares of Corteva during the fourth quarter valued at approximately $31,000. Criterion Capital Advisors LLC bought a new stake in shares of Corteva during the fourth quarter valued at approximately $32,000. Finally, Private Wealth Management Group LLC bought a new stake in shares of Corteva during the fourth quarter valued at approximately $33,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Trading Up 0.4 %

NYSE CTVA traded up $0.24 on Wednesday, hitting $53.94. 966,341 shares of the stock were exchanged, compared to its average volume of 3,520,814. Corteva, Inc. has a 52-week low of $43.22 and a 52-week high of $58.81. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.51 and a quick ratio of 0.97. The company has a market capitalization of $37.60 billion, a price-to-earnings ratio of 67.85, a P/E/G ratio of 1.47 and a beta of 0.78. The company’s 50-day moving average price is $56.01 and its two-hundred day moving average price is $51.93.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Wednesday, May 1st. The company reported $0.89 EPS for the quarter, beating the consensus estimate of $0.79 by $0.10. Corteva had a net margin of 3.32% and a return on equity of 6.68%. The business had revenue of $4.49 billion for the quarter, compared to analysts’ expectations of $4.65 billion. During the same period in the previous year, the company posted $1.16 EPS. Corteva’s revenue was down 8.0% on a year-over-year basis. Research analysts predict that Corteva, Inc. will post 2.82 EPS for the current year.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 18th. Stockholders of record on Tuesday, June 4th will be paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.19%. The ex-dividend date of this dividend is Tuesday, June 4th. Corteva’s dividend payout ratio (DPR) is presently 81.01%.

Analysts Set New Price Targets

A number of research firms have recently weighed in on CTVA. Canaccord Genuity Group lifted their price target on Corteva from $60.00 to $65.00 and gave the company a “buy” rating in a report on Friday, May 3rd. Wells Fargo & Company lifted their price target on Corteva from $66.00 to $67.00 and gave the company an “overweight” rating in a report on Friday, May 3rd. Royal Bank of Canada boosted their target price on Corteva from $62.00 to $64.00 and gave the stock an “outperform” rating in a report on Monday, May 6th. Deutsche Bank Aktiengesellschaft boosted their target price on Corteva from $62.00 to $65.00 and gave the stock a “buy” rating in a report on Monday, May 6th. Finally, Loop Capital raised Corteva from a “hold” rating to a “buy” rating and boosted their target price for the stock from $57.00 to $65.00 in a report on Monday, February 12th. Six analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, Corteva presently has a consensus rating of “Moderate Buy” and a consensus price target of $63.05.

Insider Transactions at Corteva

In other news, SVP Cornel B. Fuerer sold 39,736 shares of the company’s stock in a transaction on Tuesday, May 14th. The shares were sold at an average price of $57.41, for a total value of $2,281,243.76. Following the transaction, the senior vice president now directly owns 126,628 shares of the company’s stock, valued at $7,269,713.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other Corteva news, SVP Cornel B. Fuerer sold 39,736 shares of the stock in a transaction on Tuesday, May 14th. The shares were sold at an average price of $57.41, for a total transaction of $2,281,243.76. Following the transaction, the senior vice president now directly owns 126,628 shares of the company’s stock, valued at $7,269,713.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Samuel R. Eathington sold 31,686 shares of the stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $57.64, for a total transaction of $1,826,381.04. Following the transaction, the insider now directly owns 53,854 shares in the company, valued at $3,104,144.56. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 83,556 shares of company stock valued at $4,795,016. 0.20% of the stock is owned by insiders.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.